NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
NewcelX Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$2.63+0.13 (+5.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 1.2
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 31, 2025 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Oct 18, 2024(first seen in filings) | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Sep 27, 2024 | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |